Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25

Rhea-AI Summary

Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company, announced its participation in the Maxim Group Virtual Healthcare IT Conference on January 25, 2023. CEO Manny Krakaris will join a live webcast Doctor's Panel at 12:30 p.m. ET, while CFO Paul Ginocchio will conduct investor meetings throughout the day. The company provides ambient medical documentation solutions that enhance clinician-patient interactions by converting conversation into real-time medical notes. Augmedix aims to reduce clinician burnout and improve overall patient care through its innovative platform that leverages automated speech recognition and natural language processing.

Positive

• Participation in Maxim Group Virtual Healthcare IT Conference can enhance investor relations and visibility.
• Innovative solutions to reduce clinician burnout and improve patient satisfaction may lead to future growth.

Negative

• None.

SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its leadership team will participate in the Maxim Group Virtual Healthcare IT Conference on Wednesday, January 25, 2023. Manny Krakaris, Chief Executive Officer, will join the “Doctors Panel” which will be webcast live at 12:30 p.m. ET. Mr. Krakaris and Paul Ginocchio, Chief Financial Officer, will also host investor meetings throughout the day.

To register for the conference and schedule a meeting, visit the conference portal here. Investors interested in arranging a meeting can also contact FNK IR at augx@fnkir.com or their Maxim Group representative.   

About Augmedix

Augmedix, Inc. (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.

Augmedix is on a mission to help clinicians and patients form a human connection at the point of care without the intrusion of technology. Augmedix’s solutions extract data from natural physician-patient conversations and convert it to medical notes in real time, which are seamlessly transferred to the EHR. To achieve this, the company’s Ambient Automation Platform uses Automated Speech Recognition and Natural Language Processing, supported by medical documentation specialists.

Leveraging this platform, Augmedix’s solutions relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of physician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.

Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit augmedix.com.

Contact Information

Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com

Media:
Kaila Grafeman
Augmedix
pr@augmedix.com

FAQ

What is Augmedix's participation in the Maxim Group Conference on January 25, 2023?

Augmedix will participate in the Maxim Group Virtual Healthcare IT Conference, featuring a Doctor's Panel with CEO Manny Krakaris.

What time is Augmedix's Doctor's Panel at the conference?

The Doctor's Panel with CEO Manny Krakaris is scheduled for 12:30 p.m. ET on January 25, 2023.

How does Augmedix aim to improve patient care?

Augmedix's solutions extract data from physician-patient conversations to create real-time medical notes, enhancing care and reducing burnout.

Who can investors contact for meetings during the conference?

Investors can contact FNK IR at augx@fnkir.com or their Maxim Group representative to arrange meetings.